Imbalance in the tissue microenvironment is the main obstacle to drug delivery and
distribution in the human body. Before penetrating the pathological tissue microenvironment …

Extracellular vesicles (EVs), a cluster of cell-secreted lipid bilayer nanoscale particles,
universally exist in body fluids, as well as cell and tissue culture supernatants. Over the past …

We guide the use of organ-on-chip technology in tissue engineering applications. Organ-on-
chip technology is a form of microengineered cell culture platform that elaborates the in-vivo …

Drug delivery to the brain is crucial in the treatment for central nervous system disorders.
While significant progress has been made in recent years, there are still major challenges in …

Mesenchymal stromal cells (MSCs) continue to be proposed for use in clinical trials to treat
various diseases due to their therapeutic potential to pleiotropically influence endogenous …

A microfluidic chip was designed and fabricated to achieve visual and quantitative sensing
for the biomarker of Epstein-barr virus antibody (EBV IgG) based on TMB chromogenic unit …

The human blood–brain barrier (BBB) is a unique multicellular structure that is in critical
demand for fundamental neuroscience studies and therapeutic evaluation. Despite …

For over a decade, we have seen significant strides in the microfluidics field that have led to
the concept of microphysiological systems. These systems emerged in the early 2010s as …

The blood-brain barrier (BBB) is the most specialized biological barrier in the body. This
configuration of specialized cells protects the brain from invasion of molecules and particles …

With the accelerated development of nanotechnology in recent years, nanomaterials have
become increasingly prevalent in the medical field. The poly (lactic acid–glycolic acid) …